The global interventional cardiology devices market size was estimated at USD 10.57 billion in 2024 and is projected to reach USD 19.75 billion by 2033, growing at a CAGR of 7.25% from 2025 to 2033. The market’s growth is primarily fueled by the rising prevalence of cardiovascular diseases worldwide, the increasing preference for minimally invasive procedures, and continuous technological advancements in devices such as drug-eluting stents and bioresorbable vascular scaffolds.

An expanding elderly population, rising healthcare expenditure, and improved access to cardiac care in emerging markets further contribute to market expansion. Innovations in product design, along with the integration of artificial intelligence (AI) and advanced imaging technologies in catheter-based interventions, are also supporting the growing demand for interventional cardiology devices.

A major driver of the market is the increasing prevalence of cardiovascular diseases. Factors such as sedentary lifestyles, unhealthy dietary habits, and the rising incidence of obesity and diabetes have led to a significant global increase in coronary artery disease and other cardiac conditions. This growing disease burden has, in turn, accelerated the adoption of devices like stents, catheters, and other interventional tools for timely and effective cardiac interventions.

For example, in October 2024, the Centers for Disease Control and Prevention (CDC) reported that heart disease remains the leading cause of death in the United States, accounting for over 919,000 deaths in 2023, roughly one-third of all fatalities. On average, a person dies from cardiovascular disease every 34 seconds, and approximately 5% of adults are affected by coronary artery disease. The financial impact of heart disease was also significant, with healthcare costs, medications, and lost productivity totaling around USD 417.9 billion between 2020 and 2021.

Key Market Trends & Insights:

• The North America interventional cardiology devices market led the global industry in 2024, accounting for the largest revenue share of 45.06%. This dominance reflects the region’s well-established healthcare infrastructure, advanced cardiac care facilities, and high adoption of technologically advanced interventional devices.

• Within North America, the U.S. interventional cardiology devices market emerged as the largest contributor, driving regional growth due to increased prevalence of cardiovascular diseases, higher healthcare spending, and widespread use of minimally invasive cardiac procedures.

• In terms of product segmentation, the coronary stents category held the largest revenue share in 2024, underscoring the critical role of stents in treating coronary artery diseases. Within this category, drug-eluting stents (DES) were the most prominent segment, accounting for the highest revenue share in 2024. The popularity of DES can be attributed to their ability to reduce restenosis rates, improve patient outcomes, and complement modern interventional cardiology practices.

Order a free sample PDF of the Interventional Cardiology Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 10.57 Billion

• 2033 Projected Market Size: USD 19.75 Billion

• CAGR (2025-2033): 7.25%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

Key participants in the interventional cardiology devices market are strategically focused on driving growth by implementing a variety of initiatives. These strategies include expanding and diversifying their product portfolios to offer more advanced and innovative solutions, forming partnerships and collaborations to enhance technological capabilities and market reach, pursuing mergers and acquisitions to strengthen their competitive position, and increasing their geographical footprint to tap into new and emerging markets. Such comprehensive approaches enable companies to maintain competitiveness, address evolving customer needs, and capitalize on the growing demand for interventional cardiology devices globally

Key Players

• Abbott

• Medtronic plc

• Boston Scientific Corporation

• Cardinal Health, Inc.

• Koninklijke Philips N.V.

• Terumo Corporation

• Alvimedica Medical Technologies Inc.

• Teleflex Incorporated

• B. Braun Melsungen AG

• Biosensors International Group, Ltd.

• Meril Life Sciences Pvt. Ltd.

• BIOTRONIK SE & Co. KG

• ACIST Medical Systems, Inc.

• Asahi Intecc Co., Ltd.

• Cook Medical LLC

• Medinol Ltd.

• Merit Medical Systems, Inc.

• NuMED, Inc.

• OpSens Inc.

• Zeon Medical Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The report concludes that the global interventional cardiology devices market is expected to expand steadily over the forecast period, driven by the rising prevalence of cardiovascular diseases and increasing demand for minimally invasive procedures. Technological advancements in devices such as drug eluting stents, bioresorbable vascular scaffolds, and AI integrated imaging systems are enhancing procedural outcomes and fueling adoption. Growth is further supported by an aging population, higher healthcare spending, and improved access to cardiac care in emerging regions. Despite regulatory challenges in high risk medical device approval, ongoing innovations and strategic initiatives by key market players are expected to strengthen the market’s growth trajectory.